All this occurs through the activation of the mitogen-activated protein kinase (MAPK) pathway, which is responsible for ERα transactivation and Cyclin D1 upregulation, resulting in the stimulation of breast cancer cell growth [39,40]. Here, WNK2 is linked to breast carcinoma.